Wayne Levin
About
In The Last Decade
Wayne Levin
313 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Pharmacology 11.9k
- Molecular Biology 8.7k
- Cancer Research 4.8k
- Oncology 4.4k
- Biochemistry 3.3k
Countries citing papers authored by Wayne Levin
This map shows the geographic impact of Wayne Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Levin more than expected).
Fields of papers citing papers by Wayne Levin
This network shows the impact of papers produced by Wayne Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Levin. The network helps show where Wayne Levin may publish in the future.
Co-authorship network of co-authors of Wayne Levin
This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Levin. A scholar is included among the top collaborators of Wayne Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Levin. Wayne Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 49 | |
| 3 | 29 | |
| 4 | 335 | |
| 5 | 47 | |
| 6 | The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci breakdown → | 521 |
| 7 | 59 | |
| 8 | The P450 Gene Superfamily: Recommended Nomenclature breakdown → | 657 |
| 9 | Regulation of rat liver cytochrome P450j, a high affinity N-nitrosodimethylamine demethylase (NDMAD) | 2 |
| 10 | 25 | |
| 11 | Evidence that benzo(a)anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. | 68 |
| 12 | Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. | 210 |
| 13 | Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. | 79 |
| 14 | Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides. | 70 |
| 15 | High carcinogenicity of 2-hydroxybenzo(a)pyrene on mouse skin. | 43 |
| 16 | Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin. | 60 |
| 17 | Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. | 138 |
| 18 | Effects of drugs on the metabolism of bilirubin and other normal body constituents. | 1 |
| 19 | Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. | 189 |
| 20 | 47 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.